DBI-500

N/A

Report date: 2025/01/26 18:40:41
NME

Base Information

Drug NameDBI-500
Drug Alias Nameatypical glycolipid (Dale Biotech)DBI-500
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCD1d antigens modulators
TargetsCD1d antigens
Therapy Area/IndicationsInflammationObesityDiabetes Mellitus, Type 2 +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDale Biotech LLC
China Registration ClassN/A

Develop Information

Active CompaniesDale Biotech LLC
Inactive CompaniesN/A
Active IndicationsInflammationObesityDiabetes Mellitus, Type 2 +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A